Hi Good Morning [FIRST_NAME], Real-time clinical trials (RTCT) are becoming a reality as the FDA and HHS pilot new programs to report trial data and safety signals in near real time. For biopharma companies, CROs and imaging core labs, this shift means moving beyond today’s batch-based data model. But processing and sharing imaging data in near-real-time introduces privacy, governance and infrastructure challenges. This white paper explores what RTCT means for clinical trial imaging data and how organizations can prepare. You’ll learn: Why imaging data is uniquely difficult to process in near real time Five operational requirements for RTCT readiness, from continuous data pipelines to cross-functional alignment How to preserve data blinding and trial integrity under continuous reporting What’s required for 21 CFR Part 11 data validation and audit trails A practical 12-month roadmap for building RTCT-ready infrastructure How Flywheel helped a top 10 biopharma organization cut development costs by 33% while creating near-instant access to trial data Download the white paper to get ahead of possible FDA expectations and build a scalable path to achieving real-time clinical trials.
